KEGG   DGROUP: Disease modifying anti-rheumatic drug (DMARD)
Entry
DG01985                     DGroup                                 
Name
Disease modifying anti-rheumatic drug (DMARD)
Type
Class
Member
Gold preparations
 D00992  
Gold sodium thiomalate (USP); Sodium aurothiomalate (JP18)  <JP>
 D08521  
Sodium aurothiosulfate (INN)
 D00237  
Auranofin (JP18/USAN/INN)  <JP/US>
 D00991  
Aurothioglucose (USP)
 D07478  
Aurotioprol
Penicillamine
 D00496  
Penicillamine (JAN/USP/INN)  <JP/US>
 D08330  
Penicillamine hydrochloride
D01809  
Bucillamine (JP18/INN)  <JP>
D01146  
Iguratimod (JAN/INN)  <JP>
D00448  
Sulfasalazine (USP/INN); Salazosulfapyridine (JP18)  <JP/US>
D01395  
Actarit (JAN/INN)  <JP>
D00749  
Leflunomide (JAN/USP/INN)  <JP/US>
Tacrolimus
 D08556  
Tacrolimus (INN)
 D00107  
Tacrolimus (USP/INN); Tacrolimus hydrate (JP18)  <JP/US>
Azathioprine
 D00238  
Azathioprine (JP18/USP/INN)  <JP/US>
 D03033  
Azathioprine sodium (USP)  <US>
Methotrexate
 D00142  
Methotrexate (JP18/USP/INN)  <JP/US>
 D02115  
Methotrexate sodium  <US>
D01392  
Mizoribine (JP18/INN)  <JP>
JAK inhibitor
 DG00719  
Ruxolitinib
  D09959  
Ruxolitinib (USAN/INN)
  D09960  
Ruxolitinib phosphate (JAN/USAN)  <JP/US>
 DG02968  
Fedratinib
  D10630  
Fedratinib (USAN/INN)
  D11296  
Fedratinib hydrochloride (USAN)  <US>
 D11768  
Pacritinib (USAN/INN)  <US>
 DG00742  
Tofacitinib
  D09970  
Tofacitinib (USAN)
  D09783  
Tofacitinib citrate (JAN/USAN)  <JP/US>
 D10308  
Baricitinib (JAN/USAN/INN)  <JP/US>
 DG02829  
Upadacitinib
  D10994  
Upadacitinib (USAN/INN)
  D10995  
Upadacitinib tartrate (USAN)
  D11048  
Upadacitinib hydrate (JAN)  <JP/US>
 DG01991  
Filgotinib
  D10871  
Filgotinib (USAN/INN)
  D10872  
Filgotinib hydrochloride (USAN)
  D11106  
Filgotinib maleate (JAN/USAN)  <JP>
 DG02833  
Itacitinib
  D10944  
Itacitinib (USAN/INN)
  D10945  
Itacitinib adipate (JAN/USAN)
 DG01853  
Peficitinib
  D10653  
Peficitinib (USAN/INN)
  D10721  
Peficitinib hydrobromide (JAN/USAN)  <JP>
 D11400  
Abrocitinib (JAN/USAN)  <JP/US>
 D11046  
Delgocitinib (JAN/USAN)  <JP>
 DG01366  
Momelotinib
  D10315  
Momelotinib (USAN/INN)
  D10358  
Momelotinib dihydrochloride (USAN)
  D10889  
Momelotinib hydrochloride hydrate (JAN)
 DG02005  
Oclacitinib
  D10141  
Oclacitinib (USAN)
  D10142  
Oclacitinib maleate (USAN)
 DG03044  
Brepocitinib
  D11537  
Brepocitinib (USAN)
  D11538  
Brepocitinib tosylate (USAN)
 DG03058  
Zotiraciclib
  D11599  
Zotiraciclib (USAN)
  D11600  
Zotiraciclib citrate (USAN)
 DG03080  
Gusacitinib
  D11676  
Gusacitinib (USAN/INN)
  D11677  
Gusacitinib hydrochloride (USAN)
 DG03114  
Deuruxolitinib
  D11866  
Deuruxolitinib (USAN)
  D11867  
Deuruxolitinib phosphate (USAN)
 DG03175  
Ivarmacitinib
  D12211  
Ivarmacitinib (USAN)
  D12212  
Ivarmacitinib sulfate (USAN)
 D10365  
Gandotinib (USAN)
 D10585  
Decernotinib (USAN/INN)
 D10728  
Solcitinib (USAN/INN)
 D11970  
Ritlecitinib tosilate (JAN)
 D12118  
Nezulcitinib (USAN)
D03203  
Abatacept (USAN/INN); Abatacept (genetical recombination) (JAN)  <JP/US>
TNF inhibitor
 D00742  
Etanercept (USAN/INN); Etanercept (genetical recombination) (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN)  <JP/US>
 D02598  
Infliximab (USAN/INN); Infliximab (genetical recombination) (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 1] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 2] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 3] (JAN)  <JP/US>
 D07436  
Afelimomab (INN)
 D02597  
Adalimumab (USAN/INN); Adalimumab (genetical recombination) (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 1] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 2] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 3] (JAN)  <JP/US>
 D03441  
Certolizumab pegol (USAN/INN); Certolizumab pegol (genetical recombination) (JAN)  <JP/US>
 D04358  
Golimumab (USAN/INN); Golimumab (genetical recombination) (JAN)  <JP/US>
 DG00744  
Lenalidomide
  D04687  
Lenalidomide (JAN/USAN/INN)  <US>
  D09813  
Lenalidomide hydrate (JAN)  <JP>
 D04690  
Lenercept (USAN/INN)
 D05146  
Nerelimomab (USAN/INN)
 D05263  
Onercept (USAN/INN)
 D05393  
Pegsunercept (USAN)
 D09944  
Ozoralizumab (USAN); Ozoralizumab (genetical recombination) (JAN)
 D10187  
Pateclizumab (USAN)
 D10320  
Placulumab (USAN/INN)
D02596  
Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN)  <JP/US>
D10161  
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN)  <JP/US>
D03684  
Denosumab (USAN); Denosumab (genetical recombination) (JAN)  <JP/US>
 » expand
Class
Anti-inflammatory

» Japanese version

DBGET integrated database retrieval system